Mark Hardink
Pfizer (United States)(US)
Publications by Year
Research Areas
Analytical Chemistry and Chromatography, Chemical Synthesis and Analysis, Chemical Synthesis and Reactions, Chromatography in Natural Products, Computational Drug Discovery Methods
Most-Cited Works
- → Carbonyldiimidazole-Mediated Lossen Rearrangement(2009)179 cited
- → DBU Catalysis of N,N′-Carbonyldiimidazole-Mediated Amidations(2009)92 cited
- → On the method development of immobilized polysaccharide chiral stationary phases in supercritical fluid chromatography using an extended range of modifiers(2014)33 cited
- → Process analytical technology (PAT): applications to flow processes for active pharmaceutical ingredient (API) development(2022)25 cited
- → Chromatographic resolution of atropisomers for toxicity and biotransformation studies in pharmaceutical research(2015)21 cited
- → Synthesis of Nirmatrelvir: Development of an Efficient, Scalable Process to Generate the Western Fragment(2023)15 cited
- → Evolution of strategies to achieve baseline separation of ten anionic, water-soluble sulfated estrogens via achiral packed column supercritical fluid chromatography(2014)10 cited
- → Establishing the Human Duodenum Chip as a Surrogate for Effective Human Permeability: In Vitro and In Silico Assessment(2025)
- → ChemInform Abstract: Carbonyldiimidazole‐Mediated Lossen Rearrangement.(2010)
- → ChemInform Abstract: DBU Catalysis of N,N′‐Carbonyldiimidazole‐Mediated Amidations.(2010)